The approval allows the firm to fulfill a three-year medical distribution deal in Germany
BC-based company seeks first international weed sales by entering joint venture with DutchCanGrow
US cannabis operator reports US$8.6 million in Q1 revenues, while forecasting US$15.0 million for Q2
Wolters Kluwer will publish "Medical Marijuana: A Clinical Handbook" in September
California cannabis company expands global operations with six sales in Colombia
Spartan will use its network of volunteers and professionals to perform clinical services for Shoppers patients
Hemp flowers could create value-adding essential oil products used for beer and beyond, suggests study
Company appoints former big tobacco executive Miguel Martin as chief commercial officer
Cannabis retailer will open two locations next to Circle K convenience stores in Alberta
CannaGlobal Wellness will focus on psilocybin to promote emotional, mental and physical health
Red Cross warns pandemic will act as 'magnifier of pre-existing vulnerabilities'
Moncton-based company will also cut production and expects writedowns due to Covid-19
California-based global weed operator gains first-mover advantage in Mexico with D9C acquisition
Over 55 per cent of New Zealand respondents say they will vote yes to legal recreational cannabis in September referendum
Brightfield Group report shows many legal bud brands are recognized by 15% of Canadian users or less
Dynaleo has signed a letter of intent with California-based edibles producer Pantry
Company continues corporate reset as Booth makes final exit
The company has cut back on operating expenses in an effort to weather the current economic storm
Company gears up for in-house cannabis 2.0 launch in provinces, territories
Shift in public opinion supports push for federal legalization, says NORML director
Canadian weed giant has been working with the US FDA to get CBD food and pet products regulated
Aphria and Emblem entered supply deal in 2018 for 175,000 kilograms of cannabis. The following year Aleafia Health acquired Emblem and the deal was terminated
Cross-border acquisition deal amended due to current 'volatile financial market conditions'
Company credits current success to aggressive expansion during Covid-19
Peer-reviewed study associated cannabis use with long-term reduction of migraine frequency, less related disability and lower anti-migraine intake
Joint venture between Village Farms and Emerald Health now ships to 70% of Canada's population
Cannabis giant makes second round of aggressive cuts as industry continues to downsize amid headwinds
Allied Corp partners with MGC Pharmaceuticals to further therapy options for veterans and first responders
Company uses low-cost outdoor production for medical vape products and plans for adult-use expansion
The 30 mL, 10 mg drinkable is marketed as the first 'true alternative' to smoking weed
Canopy CEO predicts US federal legalization in 2022, which would finalize weed giant's acquisition of Acreage
Offering 'sensible rules and regulations' would better support LPs, says NORML Canada president
Unofficial guidance for the first quarter 2020 shows continued revenue growth
But the Canadian weed retailer was still unprofitable in Q1 as expenses remained high
Company says Sunens facility will support production of its industry-leading cannabis 2.0 products
The new research refutes findings from previous studies that suggested a correlation
The 420,000 square foot facility can be scaled up to 2.2M square feet of cultivation space
Company says it planted 18,000 clones outdoors, predicts Q1 revenue will jump to $12 million
Controversial retail deal decreases by three California stores and US$12.5 million
Canopy-funded initiative aims to fill knowledge gap about weed among medical professionals








































